RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shirzad Jenab to Naltrexone

Back to Details
This is a "connection" page, showing publications Shirzad Jenab has written about Naltrexone.
Shirzad Jenab
Connection Strength
0.170
Naltrexone
  1. Jenab S, Kest B, Inturrisi CE. Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment. Brain Res. 1995 Sep 11; 691(1-2):69-75.
    View in: PubMed
    Score: 0.131
  2. Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE. Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception. Eur J Pharmacol. 1998 Mar 12; 345(1):47-53.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support